Buy Stocks Easy | About Us
January 19, 2021
Buy Stocks Easy | Online Stocks

ACHN


Buy Achillion Pharmaceuticals, Inc. Stock (symbol: ACHN) Easy Online

Company Name: Achillion Pharmaceuticals, Inc.

Symbol: ACHN

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2006

ACHN Current Share Price

Today's ACHN ( Achillion Pharmaceuticals, Inc. ) opening price: $6.1500

Yesterday's ACHN ( Achillion Pharmaceuticals, Inc. ) closing price: $6.1500

Achillion Pharmaceuticals, Inc. Stock ( symbol: ACHN ) Price Chart since IPO (2006):

12 Months Achillion Pharmaceuticals, Inc. Stock ( symbol: ACHN ) Price Chart

Popular Questions about Achillion Pharmaceuticals, Inc. Public Stock ( ACHN )

A: Achillion Pharmaceuticals, Inc. stock symbol (also called stock or share ticker) is ACHN

A: Achillion Pharmaceuticals, Inc. IPO (Initial Public Offering) took place on 2006

A: Achillion Pharmaceuticals, Inc.'s stock (ACHN symbol) price at ther IPO (initial Public Offering) was $6.1500

Q: Is ACHN stock worth buying at the moment?

A: If you were looking for a long-term investment portfolio and had bought the 'Achillion Pharmaceuticals, Inc. stock (symbol: ACHN) at the beginning of 2019, at the opening share price of $2.1900, with a minimum of $200, by now your shares would be worth $18464 and your profit would be $18264 - SHOW ONLY IF PROFIT.

Buy Achillion Pharmaceuticals, Inc. Stock Easy Online

Achillion Pharmaceuticals, Inc. Stock Ticker Price Chart since IPO:





Achillion Pharmaceuticals, Inc. Stock Price Yesterday



 


Achillion Pharmaceuticals, Inc. Stock Price – Last Week




 


Achillion Pharmaceuticals, Inc. Stock Price – Last Month




 


Achillion Pharmaceuticals, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/09/1958002/0/en/Achillion-Reports-Positive-Data-from-Phase-2-Study-of-Danicopan-ACH-4471-in-Combination-with-Eculizumab-in-PNH-Patients-who-Have-an-Inadequate-Response-to-Eculizumab-Monotherapy-at.html
                            

                                
Achillion Reports Positive Data from Phase 2 Study of Danicopan (ACH-4471) in Combination with Eculizumab in PNH Patients who Have an Inadequate Response to Eculizumab Monotherapy at the 61st American Society of Hematology Meeting

                                
                                
– 2.4 g/dL mean increase in hemoglobin at 24 weeks –   – Reduction ...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/643586/5-stocks-that-pushed-russell-2000-etf-higher
                            

                                
5 Stocks That Pushed Russell 2000 ETF Higher

                                
                                
Inside the best performing stocks of the Russell 2000 ETF.


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/19/1949350/0/en/European-Medicines-Agency-Grants-PRIME-Designation-to-Danicopan-for-Treatment-of-Paroxysmal-Nocturnal-Hemoglobinuria-Patients-Who-Are-Not-Adequately-Responding-to-a-C5-Inhibitor.html
                            

                                
European Medicines Agency Grants PRIME Designation to Danicopan for Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients Who Are Not Adequately Responding to a C5 Inhibitor

                                
                                
– Phase 3 PNH initiation planned early 2020 – – Phase 3 PNH initiat...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/11/1944656/0/en/Achillion-Announces-Clearance-of-Investigational-New-Drug-Application-for-ACH-5228.html
                            

                                
Achillion Announces Clearance of Investigational New Drug Application for ACH-5228

                                
                                
BLUE BELL, Pa., Nov.  11, 2019  (GLOBE NEWSWIRE) -- Achillion Pharm...


                            

                        
                    

                


                            

                    


                        
                            https://www.fool.com/investing/2019/10/16/why-achillion-pharmaceuticals-stock-is-skyrocketin.aspx
                            

                                
Why Achillion Pharmaceuticals Stock Is Skyrocketing Today

                                
                                
Alexion Pharmaceuticals will reportedly buy clinical-stage rival Ac...


                            

                        
                    

                


                            

                    


                        
                            https://247wallst.com/healthcare-business/2019/10/16/are-shareholders-getting-enough-in-the-achillion-acquisition/
                            

                                
Are Shareholders Getting Enough in the Achillion Acquisition?

                                
                                
Achillion Pharmaceuticals Inc. (NASDAQ: ACHN) shares skyrocketed on...


                            

                        
                    

                


                            

                    


                        
                            https://www.benzinga.com/general/biotech/19/10/14601681/alexion-to-acquire-achillion-pharma-for-930m
                            

                                
Alexion To Acquire Achillion Pharma For $930M

                                
                                
Alexion Pharma (NASDAQ: ALXN) will buy Achillion Pharma (NASDAQ: AC...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/19/1962874/0/en/Achillion-Shareholders-Approve-Agreement-to-be-Acquired-by-Alexion.html
                            

                                
Achillion Shareholders Approve Agreement to be Acquired by Alexion

                                
                                
BLUE BELL, Pa., Dec.  19, 2019  (GLOBE NEWSWIRE) -- Achillion Pharm...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/09/1958002/0/en/Achillion-Reports-Positive-Data-from-Phase-2-Study-of-Danicopan-ACH-4471-in-Combination-with-Eculizumab-in-PNH-Patients-who-Have-an-Inadequate-Response-to-Eculizumab-Monotherapy-at.html
                            

                                
Achillion Reports Positive Data from Phase 2 Study of Danicopan (ACH-4471) in Combination with Eculizumab in PNH Patients who Have an Inadequate Response to Eculizumab Monotherapy at the 61st American Society of Hematology Meeting

                                
                                
– 2.4 g/dL mean increase in hemoglobin at 24 weeks –   – Reduction ...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/643586/5-stocks-that-pushed-russell-2000-etf-higher
                            

                                
5 Stocks That Pushed Russell 2000 ETF Higher

                                
                                
Inside the best performing stocks of the Russell 2000 ETF.


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/19/1949350/0/en/European-Medicines-Agency-Grants-PRIME-Designation-to-Danicopan-for-Treatment-of-Paroxysmal-Nocturnal-Hemoglobinuria-Patients-Who-Are-Not-Adequately-Responding-to-a-C5-Inhibitor.html
                            

                                
European Medicines Agency Grants PRIME Designation to Danicopan for Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients Who Are Not Adequately Responding to a C5 Inhibitor

                                
                                
– Phase 3 PNH initiation planned early 2020 – – Phase 3 PNH initiat...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/11/1944656/0/en/Achillion-Announces-Clearance-of-Investigational-New-Drug-Application-for-ACH-5228.html
                            

                                
Achillion Announces Clearance of Investigational New Drug Application for ACH-5228

                                
                                
BLUE BELL, Pa., Nov.  11, 2019  (GLOBE NEWSWIRE) -- Achillion Pharm...


                            

                        
                    

                


                            

                    


                        
                            https://www.fool.com/investing/2019/10/16/why-achillion-pharmaceuticals-stock-is-skyrocketin.aspx
                            

                                
Why Achillion Pharmaceuticals Stock Is Skyrocketing Today

                                
                                
Alexion Pharmaceuticals will reportedly buy clinical-stage rival Ac...


                            

                        
                    

                


                            

                    


                        
                            https://247wallst.com/healthcare-business/2019/10/16/are-shareholders-getting-enough-in-the-achillion-acquisition/
                            

                                
Are Shareholders Getting Enough in the Achillion Acquisition?

                                
                                
Achillion Pharmaceuticals Inc. (NASDAQ: ACHN) shares skyrocketed on...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.